Status:
COMPLETED
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Breast cancer treatment often involved radiation to the breast. A side-effect of this treatment is skin redness, itching and burning. Some patients have quite severe reactions. Our current treatment f...
Detailed Description
BackgroundRadiation therapy is an important component of treatment for breast cancer, especially in the setting of breast conservation. Even though cancer patients who are receiving radiation treatmen...
Eligibility Criteria
Inclusion
- adult age women receiving 4500cGy or 5000cGy for non-metastatic breast cancer.
- tumor bed boost allowed.
Exclusion
- patients with uncontrolled diabetes, uncontrolled eating disorder, acquired immunodeficiency syndrome, active lupus or scleroderma, a known allergy to pure aloe gel, a pre-study contact dermatitis to study creams.
- consenting procedures not completed prior to 10cGy of radiation therapy.
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT00156806
Start Date
March 1 2002
End Date
May 1 2006
Last Update
January 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2